Pancuronium bromide
| Code | Size | Price |
|---|
| CDX-P0238-M010 | 10 mg | £48.00 |
Quantity:
| CDX-P0238-M050 | 50 mg | £139.00 |
Quantity:
| CDX-P0238-M100 | 100 mg | £237.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
AMBIENT
Storage:
Short Term: +4°C, Long Term: -20°C
Documents
Further Information
Alternate Names/Synonyms:
NSC 293162
Appearance:
White to faint yellow powder or crystals.
CAS:
15500-66-0
Class:
6.1
EClass:
32160000
Form (Short):
liquid
GHS Symbol:
GHS06
Handling Advice:
Protect from light and moisture.
Hazards:
H301
InChi:
InChI=1S/C35H60N2O4.2BrH/c1-24(38)40-32-21-26-13-14-27-28(35(26,4)23-31(32)37(6)19-11-8-12-20-37)15-16-34(3)29(27)22-30(33(34)41-25(2)39)36(5)17-9-7-10-18-36;;/h26-33H,7-23H2,1-6H3;2*1H/q+2;;/p-2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-;;/m0./s1
InChiKey:
NPIJXCQZLFKBMV-YTGGZNJNSA-L
Long Description:
Chemical. CAS: 15500-66-0. Formula: C35H60Br2N2O4. MW: 732.67. Pancuronium bromide is an aminosteroid antagonist of muscle-type nicotinic acetylcholine receptors (nAChRs) acting as a typical non-depolarizing curare-mimetic muscle relaxant/neuromuscular blocking agent. Pancuronium bromide enhances anesthesia induced by isoflurane.
MDL:
MFCD00079223
Molecular Formula:
C35H60Br2N2O4
Molecular Weight:
732.67
Package Type:
Vial
PG:
III
Precautions:
P301 + P310
Product Description:
Pancuronium bromide is an aminosteroid antagonist of muscle-type nicotinic acetylcholine receptors (nAChRs) acting as a typical non-depolarizing curare-mimetic muscle relaxant/neuromuscular blocking agent. Pancuronium bromide enhances anesthesia induced by isoflurane.
Purity:
>98% (TLC)
Signal word:
Danger
SMILES:
O=C(C)O[C@H]1[C@@H]([N+]2(C)CCCCC2)C[C@@]3([H])[C@]4([H])CC[C@@]5([H])C[C@H](OC(C)=O)[C@@H]([N+]6(C)CCCCC6)C[C@]5(C)[C@@]4([H])CC[C@@]31C.[Br-].[Br-]
Solubility Chemicals:
Soluble in water (40mg/ml), ethanol or DMSO.
Transportation:
Excepted Quantity
UN Nummer:
2811
UNSPSC Category:
Biochemical Reagents
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.
References
(1) W.R. Buckett, et al.; Br. J. Pharmacol. Chemother. 32, 671 (1968) | (2) D. Komesaroff & J.E. Field; Med. J. Aust. 1, 908 (1969) | (3) P.R. Saxena & I.L. Bonta; Arch. Int. Pharmacodyn. Ther. 189, 410 (1971) | (4) T.M. Speight & G.S. Avery; Drugs 4, 163 (1972) (Review) | (5) M. Liu & J.P. Dilger; Mol. Pharmacol. 75, 166 (2009) | (6) Y. Miyazaki, et al.; J. Anesth. 30, 671 (2016)